Navigation Links
Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
Date:12/11/2008

based on 24 months of treatment. Further follow-up will be needed to determine long-term results, safety and efficacy.

Femara is also approved for the extended adjuvant treatment of early stage breast cancer in postmenopausal women who are within three months of completion of five years of tamoxifen therapy. The benefits of Femara in clinical trial are based on 24 months of treatment. Further follow-up will be needed to determine long-term results, including side effects.

In addition, Femara is approved for the treatment of postmenopausal women with estrogen receptor-positive or estrogen receptor-unknown breast cancer that has spread to another part of the body (metastatic cancer).

Important Safety Information

You should not take Femara if you are premenopausal. Your doctor should discuss the need for adequate birth control if you have the potential to become pregnant, if you are not sure of your postmenopausal status, or if you recently became postmenopausal. Femara is only indicated in postmenopausal women. Talk to your doctor if you're allergic to Femara or any of its ingredients. You should not take Femara if you are pregnant as it may cause fetal harm. Some women reported fatigue and dizziness with Femara. Until you know how it affects you, use caution before driving or operating machinery. Some patients taking Femara had an increase in cholesterol. Additional follow-up is needed to determine the risk of bone fracture associated with long-term use of Femara.

In the adjuvant setting, commonly reported side effects are generally mild to moderate. The most common side effects seen with Femara include hot flashes, joint pain, night sweats, weight gain, nausea, tiredness, other heart-related events and bone fractures. Other less commonly reported side effects include vaginal bleeding, blood clots, other cancers, osteoporosis, stroke, heart attack and endom
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
2. Video: New Survey Finds Mothers See Influenza as a Serious Health Threat, but Often Dont Get Their Families Vaccinated
3. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
4. Video: Answer to Curing a Failing Heart May Exist in Bodys Own Do-It-Yourself Repair Kit
5. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
6. Video: The Looming Crisis in Cancer Drug Development: 97% of Adult Cancer Patients Do Not Take Advantage of Clinical Trial Programs
7. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
8. Video: Prognosis Split for Hip Fracture and Hip Replacement in the Elderly
9. Video: Resveratrol-based Nutriceutical (Longevinex(R)) Induces Favorable Changes on Gene Expression in Mouse Heart At Doses 17-320 Times Lower Than Prior Studies
10. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
11. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 20, 2015 Pharmaceutical Research and Manufacturers of ... last year in the research and development (R&D) of ... majority of all biopharmaceutical R&D spending – both public ... . The new R&D numbers, the result of ... in the newly released PhRMA 2015 Biopharmaceutical ...
(Date:4/20/2015)... April 20, 2015 Stand Up To Cancer (SU2C) and ... $20 million Dream Team to attack the number one cancer ... Meeting of the American Association for Cancer Research (AACR), Scientific ... people in the United States will ... 158,040 will die from it, making lung cancer the leading ...
(Date:4/20/2015)... PALO ALTO, Calif. , April 20, 2015 ... study demonstrate positive trends in the ability of ... slow the progression of amyotrophic lateral sclerosis (ALS, ... over a 6-month treatment period. While NP001,s slowing ... of the study was not statistically significant, clinically ...
Breaking Medicine Technology:PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3New SU2C-American Cancer Society Lung Cancer Dream Team Announced 2New SU2C-American Cancer Society Lung Cancer Dream Team Announced 3New SU2C-American Cancer Society Lung Cancer Dream Team Announced 4New SU2C-American Cancer Society Lung Cancer Dream Team Announced 5New SU2C-American Cancer Society Lung Cancer Dream Team Announced 6Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 2Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 3Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 4Published Phase 2 Results Demonstrate Neuraltus Pharmaceuticals' NP001 Potential Efficacy and Safety in ALS 5
... N.Y., March 2, 2011 Lixte ... that the company has received a $244,479.25 grant ... awarded to further development and commercialization of Lixte,s novel anti-cancer ... the Patient Protection and Affordable Care Act of 2010 to ...
... 2011 InspireMD , developer ... has expanded its MGuard production facilities to meet the ... accelerating demand for MGuard include the recent recommendation of ... be considered for PCI of highly thrombotic or SVG ...
Cached Medicine Technology:Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government 2InspireMD Boosts MGuard Production Capacity 2
(Date:4/20/2015)... Lake City, Utah (PRWEB) April 20, 2015 ... End of Employer-Provided Health Insurance: Why It’s Good for ... 30, 2015. , Paul Zane Pilzer and Rick Lindquist ... of Employer-Provided Health Insurance: Why It’s Good for You ... to our nation’s employer health insurance woes - employer-funded ...
(Date:4/20/2015)... New York (PRWEB) April 20, 2015 ... association representing the U.S. health insurance industry, is ... result of the recent controversy involving surgical tools ... letter to U.S. Senator Robert Casey (D-PA) dated ... concerns surrounding uterine morcellation point to “serious gaps ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 “ Verus ... monthly Tech Report, which features the latest and coolest ... expert and special reporter for NewsWatch, conducted the review ... for a variety of purposes. , According to CNET, ... shattered screen in 2013. It’s unfortunate that smartphones break ...
(Date:4/20/2015)... 20, 2015 Northern Westchester Hospital ... Medicaid Services introduced their new 5-star “Patient Experience” rating ... of Healthcare Providers and Systems) survey of hospital patient ... their experiences during a recent hospital stay. ... 2013 through June 30, 2014 can be reviewed online ...
(Date:4/20/2015)... Dallas, Texas (PRWEB) April 20, 2015 ... Global Amlodipine Besylate Industry is a professional and ... global Amlodipine Besylate Market with a ... companies included in the amlodipine besylate market research ... Sun Pharmaceutical, Dr. Reddy's Lab., Par Pharma, Cadila ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 2Health News:Zane Benefits Announces Complimentary Book Giveaway On GoodReads: The End of Employer-Provided Health Insurance: Why It's Good for You and Your Company 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 2Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 3Health News:Power Morcellator Lawyers at Bernstein Liebhard LLP Comment on Insurance Trade Group’s Call for Greater Regulation of Medical Devices 4Health News:Attractive and Durable Phone Cases were Featured on NewsWatch Television 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 2Health News:Global Amlodipine Besylate Industry 2015-2020 Forecast Analysis Report 3
... The ... by empowering its patients with education about liposuction and body sculpting procedures, reaffirming their trust ... ... its commitment to patient education. The Soluna MD staff, led by general and cosmetic surgeon ...
... , ... California family whose child is thriving in the special education ... teaching fear through over protectiveness. This family is sharing their story of ... lack of sight due to an extremely premature birth and its complications. ...
... ... and reduced stress by aiding in the creation of healthy serotonin levels , ... Springville, UT (PRWEB) June 16, 2010 -- ... more restorative and restful sleep ; reduces cravings for junk food; and assists with ...
... experts assembled by the American Diabetes Association and ... suggests cancer incidence is associated with diabetes as ... The new report reviews the state of science ... risk factors common to both diseases; possible biologic ...
... ... to Colorado as Executive Director of the Linda Crnic Institute for Down syndrome at the ... ... MD, PhD, has been tapped to become the first Executive Director of the Linda ...
... virus that causes chickenpox and shingles could lead to improved ... the University of Edinburgh devised a technique to separate the ... to a biochip, before incubating the chip with blood from ... able to pinpoint which proteins in the virus triggered a ...
Cached Medicine News:Health News:Miami's Soluna MD Educates Patients, Gains International Reputation for Excellence in Laser Lipo plus Ultrasound Technique, SmartLipo™ Ultra 2Health News:Miami's Soluna MD Educates Patients, Gains International Reputation for Excellence in Laser Lipo plus Ultrasound Technique, SmartLipo™ Ultra 3Health News:California Family Raising Confident, Blind Child Sharing Successes to Change Perceptions of Blindness 2Health News:California Family Raising Confident, Blind Child Sharing Successes to Change Perceptions of Blindness 3Health News:California Family Raising Confident, Blind Child Sharing Successes to Change Perceptions of Blindness 4Health News:Healthy Serotonin Levels Shown to Positively Affect many Important Functions of the Mind and Body. 2Health News:Experts explore emerging evidence linking diabetes and cancer 2Health News:Experts explore emerging evidence linking diabetes and cancer 3Health News:Renowned Geneticist Heralds in New Era for People with Down Syndrome 2Health News:Renowned Geneticist Heralds in New Era for People with Down Syndrome 3Health News:Renowned Geneticist Heralds in New Era for People with Down Syndrome 4
ELISA kit for the quantitative determination of autoantibodies to IA-2 in serum...
Inquire...
Bench Top Class I Containment Cabinet Personnel Protection...
Inquire...
Medicine Products: